scispace - formally typeset
R

Renata Risi

Researcher at Sapienza University of Rome

Publications -  26
Citations -  786

Renata Risi is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 18 publications receiving 313 citations.

Papers
More filters
Journal ArticleDOI

Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine.

TL;DR: In this article, the authors explored variables associated with the serological response following COVID-19 mRNA vaccine and found that higher waist circumference, smoking, hypertension, and longer time elapsed since second vaccine inoculation were associated with lower Ab titres, independent of BMI, age and gender.
Journal ArticleDOI

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19.

TL;DR: In this paper, the authors explored the impact on COVID-19 severity of abdominal fat as a marker of body composition easily collected in patients undergoing a chest CT scan and found that abdominal fat was a marker for worse clinical outcomes in patients with COVID19.
Journal ArticleDOI

Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature

TL;DR: Clinical evidence, metabolic pathways involved, and strict categorization of dietary interventions involved in the ketogenic diet and nonalcoholic fatty liver disease are focused on, to provide an accurate revision of current literature on KDs and NAFLD.
Journal ArticleDOI

Obesity and SARS-CoV-2: A population to safeguard.

TL;DR: Understanding the link between obesity and SARS‐CoV‐2 is crucial, as this could aid proper tailoring of immunomodulatory treatments, together with improving stratification among those possibly requiring critical care.
Journal ArticleDOI

Very-Low-Calorie Ketogenic Diets With Whey, Vegetable, or Animal Protein in Patients With Obesity: A Randomized Pilot Study.

TL;DR: VLCKDs based on whey or vegetable protein have a safer profile and result in a healthier microbiota composition than those containing animal proteins, and are more effective in maintaining muscle performance.